SO
LBPH

STRS Ohio’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

STRS Ohio’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,200
Closed -$19K – 2071
2023
Q4 		$19K Hold
3,200
– – ﹤0.01% 1852
2023
Q3 		$17K Hold
3,200
– – ﹤0.01% 1885
2023
Q2 		$23K Buy
+3,200
New +$24.2K ﹤0.01% 1878

Other funds holding LBPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

STRS Ohio's LBPH Position: Q1 2024 in Review

STRS Ohio sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q1 2024, closing a stake of 3,200 shares — an estimated $19K sold.

STRS Ohio first reported a position in LBPH in Q2 2023 and held it in 3 quarters. The position peaked at $23K in Q2 2023. 105 funds tracked by Wall St. Rank hold LBPH as of Q1 2024.

  • STRS Ohio reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • STRS Ohio sold 3,200 Longboard Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $19K.
  • STRS Ohio first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • STRS Ohio's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $23K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on STRS Ohio's 13F filing for Q1 2024, filed 13 May 2024.